🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kevin Rubenstein

National Institutes of Health

ORCID: 0000-0003-3516-5932

Also affiliated with Frederick National Laboratory for Cancer Research

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.374Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Pediatric SARS-CoV-2 long term outcomes study (PECOS): cross sectional analysis at baseline

Pediatric Research(2024)10.1038/s41390-024-03777-1
Top 48%
0.374DataRank
Top 48%7 citations

Lauren Arrigoni, Alexandra B. Yonts, Kevin Rubenstein, James E. Bost, Max T. Wolff +45 more

Papers

Driven by 7 papers — median percentile 52. Top paper: “SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir”.

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae198
N/A
0.439DataRank · unranked
13 citations

Kevin Rubenstein, Viviane Callier, Katy Shaw-Saliba, Adam Rupert, Robin Dewar +94 more

Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial

Annals of Internal Medicine(2022)10.7326/m22-2116
N/A
0.434DataRank · unranked
6 citations

Tyler Bonnett, Kevin Rubenstein, David A Lindholm, Rekha R. Rapaka, Sarah B. Doernberg +39 more

Pediatric SARS-CoV-2 long term outcomes study (PECOS): cross sectional analysis at baseline

Pediatric Research(2024)10.1038/s41390-024-03777-1
Top 48%
0.374DataRank
Top 48%7 citations

Lauren Arrigoni, Alexandra B. Yonts, Kevin Rubenstein, James E. Bost, Max T. Wolff +45 more

Hepatitis C Care Pathway Associated With Increased Screening, Confirmation, and Diagnosis Communication to Patients

Clinical Gastroenterology and Hepatology(2020)10.1016/j.cgh.2019.12.038
N/A
0DataRank · unranked
7 citations

Kevin Rubenstein, M.Cabell Jonas, Yan Sun, Michael A. Horberg, Bernadette C. Loftus +1 more

Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE)

PLoS ONE(2022)10.1371/journal.pone.0273914
N/A
0DataRank · unranked
9 citations

Kathryn Shaw‐Saliba, Lori E. Dodd, Robin Dewar, Sylvain Laverdure, Shawn T. Brown +49 more

Prospective cohort study of patient demographics, viral agents, seasonality, and outcomes of influenza-like illness in Mexico in the late H1N1-pandemic and post-pandemic years (2010-2014)

IJID Regions(2024)10.1016/j.ijregi.2024.100394
N/A
0DataRank · unranked
3 citations

Paola del Carmen Guerra-de-Blas, Ana A. Ortiz‐Hernández, Kevin Rubenstein, Ana M. Ortega‐Villa, Alejandra Ramírez‐Venegas +12 more

Futility Monitoring in Clinical Trials

Statistics in Medicine(2025)10.1002/sim.70157
N/A
0DataRank · unranked
1 citations

Megan C. Grieco, Kevin Rubenstein, Jing Wang, Michael A. Proschan, Ana M. Ortega‐Villa